Skip to content
★ Sign in to follow
SM

Shanghai Model Organisms Center, Inc. Stock: price and insider trades · China

南模生物

CN·Mcap CN¥4.3B

Shanghai Model Organisms Center, Inc.: what insiders have been doing

Shanghai Model Organisms Center, Inc. has a thin disclosure history in our data (latest filing: 15 July 2026). New filings will appear here as soon as they are published. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3,123
1 ops. · all time

Who traded when

BuySale
王津津1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 16,331 of 26,897 companies
44.9
score / 100
Value
30
Quality
60
FCF yld1.5%
Earn yld0.9%
EV/EBITDA40.5x
ROE0.7%
Gross mgn52%
Net mgn7.5%
Debt/EBITDA0.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥55.40
Analyst consensus
·
Income statement
RevenueCN¥421M
Gross profitCN¥217.6M52% margin
EBITDACN¥86.7M21% margin
Net incomeCN¥31.4M4.9% margin
Valuation
PER (trailing)178.7x
P/Book2.5x
Beta0.30
Balance sheet & cash
Market capCN¥4.3B
Total debtCN¥56.8M
Free Cash FlowCN¥51.3M
Debt / Equity3%
Profitability & ownership
ROE1.3%
ROA-0.2%
% insiders73.7%
% institutions2.5%
Last declaration on 15 July 2026
Declarations1 total
  • ▼
    董事,核心技术人员Executives
    24,084 CNY15SSE
    600 shares@ CN¥309.5315100.0% of flowA股XSHGSSE:273000000831724900

1 of 1 declaration

About Shanghai Model Organisms Center, Inc.

Nanmo Biology is a company listed on the Shanghai Stock Exchange, specializing in the biopharmaceutical sector. It focuses on the research and development of innovative solutions for disease treatment.